Vidwan-ID : 127059



  • Dr Gopal Lal Khatik

  • Assistant Professor
  • National Institute of Pharmaceutical Education and Research, Raebareli
Publications 2006 - 2024

Publications

  • 71
    Journal Articles
  • 5
    Book Chapter
  • 25
    Review
  • 8
    Short Survey
  • 2
    Editorial
  • 4
    Projects
  • 10
  • 2
  • 3
  • 77

Citations / H-Index

1531 Citations
21 h-index
1213 Citations

Altmetrics

78
15
17
245
4

Google Scholar

Co-author Network


Expertise

Medicinal Chemistry

Drug design, Synthesis and Evalulation

Personal Information

Dr Gopal Lal Khatik

Male
Medicinal Chemistry National Institute of Pharmaceutical Education and Research, Raebareli, Sarojini Nagar
Lucknow, Uttar Pradesh, India - 226002


Experience

  • Assistant Professor

    Department of Medicinal Chemistry

    National Institute of Pharmaceutical Education and Research, Raebareli

  • Associate Professor

    Lovely Professional University

  • Assistant Professor

    Lovely Professional University


Qualification

  • PhD

    National Institute of Pharmaceutical Education and Research, Mohali


Honours and Awards

2019

Research Excellence

Lovely Professional University, Jalandhar

2018

Research Excellence

Lovely Professional University, Jalandhar

2017

Research Excellence

Lovely Professional University, Jalandhar

Read More
2019

Research Excellence

Lovely Professional University, Jalandhar

2018

Research Excellence

Lovely Professional University, Jalandhar

2017

Research Excellence

Lovely Professional University, Jalandhar

2016

Research Excellence

Lovely Professional University, Jalandhar

2015

Young Scientist

SERB

Read Less

Doctoral Theses Guided

2019

Design, Synthesis and Evaluation of Novel Heterocyclic Scaffolds as Potential Anti-Diabetic Agents Targeted to PPAR α/γ Dual Agonist

Paranjeet Kaur, Lovely Professional University

2019

Development of Janus Emulsion containing Trigonella foenum- graecum and Zingiber officinale for reducing the pain intensity in primary dysmenorrheal condition

Diksha Puri, Lovely Professional University

2019

Design, Synthesis and Evaluation of Novel Heterocyclic Scaffolds as Potential Anti-Diabetic Agents Targeted to PPAR α/γ Dual Agonist

Paranjeet Kaur, Lovely Professional University

2019

Development of Janus Emulsion containing Trigonella foenum- graecum and Zingiber officinale for reducing the pain intensity in primary dysmenorrheal condition

Diksha Puri, Lovely Professional University

Read Less

Membership In Professional Bodies

2019

Indian Science Congress Association (ISCA), Kolkata, INDIA

Lifetime member

2019

Society of Pharmaceutical Education & Research (SPER)

Lifetime member

2015

Indian Pharmacy Graduate Association (IPGA), New Delhi INDIA

Lifetime member

Read More
2019

Indian Science Congress Association (ISCA), Kolkata, INDIA

Lifetime member

2019

Society of Pharmaceutical Education & Research (SPER)

Lifetime member

2015

Indian Pharmacy Graduate Association (IPGA), New Delhi INDIA

Lifetime member

2012

Indian Pharmaceutical Association (IPA) Mumbai, INDIA

Lifetime member

2012

Chemical Research Society of India (CRSI) Banglore, INDIA

Lifetime member

Read Less

Membership In Committees

2020

Drug Discovery Hackathon 2020 (DDH2020)

Expert Member

2020

Drug Discovery Hackathon 2020 (DDH2020)

Expert Member

Read Less

Research Projects

Designing of senolytic agents for the treatment of Alzheimer’s disease

Funding Agency : SERB

Development of modified kynurenic acid-based scaffolds for treatment of post-traumatic stress disorder

Funding Agency : UPCST

Development of SOPs and Standardization of Different Preparation Techniques of Netra Putapaka Formulation for Ophthalmic Use

Funding Agency : CCRAS

Read More

Designing of senolytic agents for the treatment of Alzheimer’s disease

Funding Agency : SERB

Development of modified kynurenic acid-based scaffolds for treatment of post-traumatic stress disorder

Funding Agency : UPCST

Development of SOPs and Standardization of Different Preparation Techniques of Netra Putapaka Formulation for Ophthalmic Use

Funding Agency : CCRAS

Design, synthesis, and evaluation of novel heterocyclic scaffolds as potential antidiabetic agents targeted to PPARα/γ dual agonist

Funding Agency : SERB

Read Less

Patents



Read Less